biguanides has been researched along with Thrombosis in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin treatment in patients with type 2 diabetes mellitus affects the expression of inflammatory cytokines and subsequently modifies the thrombotic mechanisms in patients with coronary atherosclerosis, independently from the duration of diabetes and the extend of coronary artery disease." | 2.73 | Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. ( Antoniades, C; Bosinakou, E; Latsios, G; Marinou, K; Papageorgiou, N; Siasos, G; Stefanadi, E; Stefanadis, C; Tentolouris, C; Tousoulis, D; Tsioufis, C, 2007) |
| "Platelet thrombosis is the main pathogeny resulting in the low curability of ischemic stroke, a leading cause of mortality and disability worldwide." | 1.56 | Novel potent antiplatelet thrombotic agent derived from biguanide for ischemic stroke. ( Chen, Z; He, Y; Huang, W; Ji, C; Lee, KH; Li, S; Li, Y; Ming, Y; Morris-Natschke, SL; Niu, H; Wei, Z; Xin, G; Xing, Z; Yang, X; Yu, K; Zhang, B; Zhang, J; Zhang, X, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Xin, G | 1 |
| Ming, Y | 1 |
| Ji, C | 1 |
| Wei, Z | 1 |
| Li, S | 1 |
| Morris-Natschke, SL | 1 |
| Zhang, X | 1 |
| Yu, K | 1 |
| Li, Y | 1 |
| Zhang, B | 1 |
| Zhang, J | 1 |
| Xing, Z | 1 |
| He, Y | 1 |
| Chen, Z | 1 |
| Yang, X | 1 |
| Niu, H | 1 |
| Lee, KH | 1 |
| Huang, W | 1 |
| Antoniades, C | 1 |
| Tousoulis, D | 1 |
| Marinou, K | 1 |
| Papageorgiou, N | 1 |
| Bosinakou, E | 1 |
| Tsioufis, C | 1 |
| Stefanadi, E | 1 |
| Latsios, G | 1 |
| Tentolouris, C | 1 |
| Siasos, G | 1 |
| Stefanadis, C | 1 |
| Fearnley, GR | 1 |
1 trial available for biguanides and Thrombosis
| Article | Year |
|---|---|
Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
Topics: Aged; Biguanides; Blood Coagulation Factors; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dru | 2007 |
2 other studies available for biguanides and Thrombosis
| Article | Year |
|---|---|
Novel potent antiplatelet thrombotic agent derived from biguanide for ischemic stroke.
Topics: Administration, Oral; Animals; Biguanides; Brain Ischemia; Dose-Response Relationship, Drug; Male; M | 2020 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation | 1971 |